StockData
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. (AVXL) stock

AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.74−0.08 (-9.49%)

Close on Nov 17, 2026Market cap $68.60MP/E –Yield –

Anavex Life Sciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2014 it was -$2.97M. The highest annual figure on record is -$2.14M in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2014Sep 30, 2014-$2.97M–
FY2013Sep 30, 2013-$2.14M–
FY2012Sep 30, 2012-$4.32M–
FY2011Sep 30, 2011-$6.18M–
FY2010Sep 30, 2010-$5.65M–

More Anavex Life Sciences figures

See a number that looks wrong?